Boston Scientific (BSX) Raw Materials (2009 - 2026)

Boston Scientific has disclosed Raw Materials across 18 years of filings, most recently posting $928.0 million for Q1 2026.

• Raw Materials for Q1 2026 came in at $928.0 million, up 10.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $928.0 million (up 10.08% YoY), and the FY2025 annual result was $849.0 million, up 3.66% from the prior year.
• Raw Materials came in at $928.0 million for Q1 2026 at Boston Scientific, up from $849.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $928.0 million in Q1 2026 to a low of $499.0 million in Q1 2022.
• The 5-year median for Raw Materials is $818.0 million (2024), against an average of $743.2 million.
• Across the five-year window, Raw Materials soared 41.09% in 2023 and retreated 1.65% in 2025, its largest moves.
• Boston Scientific's Raw Materials stood at $548.0 million in 2022, then jumped by 41.06% to $773.0 million in 2023, then rose by 5.95% to $819.0 million in 2024, then gained by 3.66% to $849.0 million in 2025, then grew by 9.31% to $928.0 million in 2026.
• The last three Raw Materials figures came in at $928.0 million (Q1 2026), $849.0 million (Q4 2025), and $849.0 million (Q3 2025), per Business Quant data.